MedTrace Logo

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD)

NCT04285047 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2020-02-26

No results posted yet for this study

Summary

APEX COPD is registry to provide a mechanism to standardize, store and utilize data to enable greater power to answer key research questions, and to improve patient outcomes in COPD primary care.

Conditions

  • Chronic Obstructive Pulmonary Disease (13645005)

Interventions

OTHER

Advancing Patient Experience (APEX) in COPD

Involves both EMR and PRIO data

Sponsors & Collaborators

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • DARTNet Institute

    collaborator OTHER_GOV

  • American Academy of Family Physicians National Research Network (AAFP NRN)

    collaborator UNKNOWN

  • Respiratory Effectiveness Group

    collaborator OTHER

  • Optimum Patient Care

    lead OTHER

Principal Investigators

  • Wilson D Pace, MD · Professor

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-23
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04285047 on ClinicalTrials.gov